BMS announces new head of major markets

6 September 2023

Dr Monica Shaw has joined the commercial leadership team of US pharma major Bristol Myers Squibb’s (NYSE: BMY) as senior vice president, major markets.

In this role, Dr Shaw oversees the company’s largest markets outside of the USA, including Canada and Western Europe, all of which are significant growth drivers for Bristol Myers as the company launches new innovative medicines, while carrying out our mission to help patients prevail over serious disease.

Dr Shaw joins BMS from Swedish oncology focused biotech Oncopeptides (Nasdaq Stockholm: ONCO), where she served as chief executive. Previously, she held international leadership roles at GSK (LSE: GSK)/ViiV Healthcare, Merck Serono and Novartis (NOVN: VX) and has launched more than 15 products through Phase III to commercialization. Dr Shaw brings broad experience having worked across immunology, dermatology, oncology, virology, neurology and rare diseases. She began her career as a physician with the National Health Service in the UK, working across different hospital specialties.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK